Part D Plans Undercut Generics In Favor Of Brands Only In 'Limited Instances' – CMS

CMS will not require Medicare Part D sponsors to cover generic drugs on lowest cost sharing tiers after all,  following review of current formulary placement and generic drug access among plans.

Brand Name or Generic - Traffic sign with two options - customer and dilemma of buying branded product vs no name commodity. Question of price and quality

More from Market Access

More from Pink Sheet